GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

Turns out that you can still text and make phone calls with Opal activated – news to me” So, unplugging at MASH was, as ...

Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

CJ Abrams hit the game's first pitch for the first of his two home runs and the visiting Washington Nationals went on to beat the staggering Baltimore Orioles 10-4 on Sunday afternoon.

Aroosha Sarrafi tells Health her story of getting diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), a ...

A brilliant performance in a pacy Red Bull — plus some lucky timing — pulled Max Verstappen clear of the pack in the 2025 ...

On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...